Clinical Trial Update: A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

View source ↗

Summary

Takeda-sponsored database survey compares the risk of haemorrhage between vortioxetine and selective serotonin reuptake inhibitors in participants with major de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SSRIs (selective serotonin reuptake inhibitors) (selective serotonin reuptake inhibitors)
• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Status: COMPLETED | Results posted: 2025-03-03